Lycera Achieves archetypal Milestone in Merck investigating Collaboration MarketWatch (press release) The collaboration is focused on developing drug candidates that have the possible to treat major response diseases such as creaky arthritis, psoriasis , inflammatory bowel disease and aggregate sclerosis. In March, the companies announced an ... and more » Link To Article
No comments:
Post a Comment